Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Albemarle Names New President
An industry veteran with over 20 years of experience, Mr Kissam joined Albemarle as VP of General Counsel and Secretary in 2003. Since that time, he has held
An industry veteran with over 20 years of experience, Mr Kissam joined Albemarle as VP of General Counsel and Secretary in 2003. Since that time, he has held
Vermillion’s OVA1 is a protein-based in vitro diagnostic multi-variate index assay (IVDMIA), a new class of software-based diagnostics, cleared by the FDA. The test utilizes five well-established biomarkers
Alexandra Wyke, head of PatientView, said many patients’ groups, majority in the US, had expressed concerns about soaring drug prices and lack of patient assistance programmes to low
Palliative treatment helps to relieve symptoms associated with advanced prostate cancer. Abott’s Lupron Depot works by suppressing the production of the hormone testosterone. The decrease in testosterone, which
Bayer said that a similar designation has already been granted by the European Medicines Agency. Ciprofloxacin DPI is an investigational drug device combination that combines ciprofloxacin dry powder
Archexin is a potent inhibitor of Akt protein kinase in the treatment of cancer. The drug is being developed to treat solid tumors and has US FDA Orphan
The acquisition also provides new channels for maximizing the potential of converting sanofi-aventis’ prescription medicines to over-the-counter (OTC) products, beginning with Allegra (fexofenadine hydrochloride), which is expected to
An independent Data Safety Monitoring Committee (DSMC) recommended A4021018 to be stopped after concluding that the addition of figitumumab to erlotinib is unlikely to demonstrate an improvement in
CALGB 90401 is a multicenter, randomized, double-blinded, placebo-controlled Phase III study designed to evaluate Avastin plus docetaxel chemotherapy and prednisone, compared to docetaxel chemotherapy and prednisone alone in
Under the terms of the agreement, Ipsen has granted Rhythm an exclusive worldwide license for research, development and commercialization of its melanocortin and ghrelin programs originating from Ipsen